文献速递主动脉疾病

采用定制Relay开窗与扇形支架进行主动脉弓近端锚定区治疗主动脉弓内侧弯曲病变

Proximal sealing in the aortic arch for inner curve disease using the custom Relay scalloped and fenestrated stent graft.
PubMed 文献 · J Vasc Surg · 2024-07-26

本研究分析了意大利10个中心2014年1月至2022年12月连续49例使用定制近端扇形或开窗Relay支架行胸主动脉腔内修复(TEVAR)、近端锚定区位于主动脉弓的患者。技术成功率为97.9%(48/49),术中I型内漏1例(2.0%)、III型内漏1例(2.0%),无院内死亡、主要不良事件或逆行性主动脉夹层,观察到3例轻微卒中(6.1%)。平均随访36.3±21.3个月期间,I至III型内漏率和再干预率均为4.1%,4例(8.2%)死亡。作者认为定制扇形和开窗TEVAR可能为主动脉弓病变提供可接受的替代治疗方案,需大规模研究评估长期耐久性。

要点

  • 技术成功率为97.9%(48/49),1例(2.0%)因释放不准确。
  • 术中检测到I型内漏1例(2.0%)和III型内漏1例(2.0%)。
  • 平均随访36.3±21.3个月,I至III型内漏率和再干预率均为4.1%。

核心结论

  • 作者认为早期和中期结果提示扇形和开窗TEVAR可能为主动脉弓病变提供可接受的替代治疗选择。
  • 作者指出需要大规模研究评估该技术的长期耐久性。

研究设计与样本

  • 回顾性纳入意大利10个中心2014年1月至2022年12月连续49例使用定制近端扇形或开窗Relay支架行TEVAR、近端锚定区位于主动脉弓的患者。
  • 终点包括技术成功、术中主要不良事件发生率、释放准确性、早期神经系统并发症、内漏和逆行性主动脉夹层发生率。

主要发现

  • 中位年龄70.1岁(四分位距23-86岁),男性占65.3%。
  • 治疗指征为动脉粥样硬化性动脉瘤59.2%、穿透性主动脉溃疡22.4%。
  • 支架配置为近端开窗55.1%、扇形44.9%;近端锚定区0区25例(51%)、1区14例(28.6%)、2区10例(20.4%);主动脉上分支去分支手术38例(77.5%)。
  • 技术成功率为97.9%(48/49),1例(2.0%)释放不准确;术中I型内漏1例(2.0%)、III型内漏1例(2.0%);无院内死亡、主要不良事件或逆行性夹层;轻微卒中3例(6.1%)(美国国立卫生研究院卒中量表评分≤4)。
  • 平均随访36.3±21.3个月,I至III型内漏率和再干预率均为4.1%;随访期间死亡4例(8.2%),其中腹主动脉破裂1例(2.1%)、非主动脉原因3例(6.1%)。

临床怎么用

  • 作者认为扇形和开窗TEVAR可能为主动脉弓病变提供可接受的替代治疗选择。

局限性

  • 作者指出需要大规模研究评估该技术的长期耐久性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to analyze early and midterm results of custom-made proximal scallop and fenestrated stent grafts for thoracic endovascular aortic repair (TEVAR) with a proximal landing zone (PLZ) in the aortic arch. METHODS: All consecutive patients treated with the custom made proximal scalloped and fenestrated Relay stent grafts (Terumo Aortic Bolton Medical Inc.) in 10 Italian centers between January 2014 and December 2022 were included. The primary end points were technical success, incidence of intraoperative major adverse events, deployment accuracy, and rate of early neurological complications, endoleaks (ELs) and retrograde aortic dissection. RESULTS: During the study period, 49 patients received TEVAR with Relay custom-made endograft in Italy were enrolled. The median patient age was 70.1 years (interquartile range, 23-86 years) and 65.3% were male. The indication for treatment was atherosclerotic aneurysms in 59.2% of cases and penetrating aortic ulcer in 22.4%. The endograft configuration was proximal fenestration in 55.1% and scallop in 44.9%. The proximal landing zone was zone 0 in 25 cases (51%), zone 1 in 14 cases (28.6%), and zone 2 in 10 cases (20.4%). The supra-aortic debranching procedures were 38 (77.5%). Technical success was 97.9% (48/49) owing to one case (2.0%) of inaccurate deployment. Intraoperatively, one (2.0%) type Ia and one (2.0%) type III EL were detected. There were no cases of in-hospital mortality, major adverse events, or retrograde dissection. Three minor strokes (6.1%) (National Institutes of Health Stroke Scale score of ≤4) were observed. At a mean follow-up time of 36.3 ± 21.3 months the rate of types I to III ELs and reintervention was 4.1%, respectively. Four patients (8.2%) died during the follow-up period, one (2.1%) from abdominal aortic rupture and three (6.1%) from nonaortic causes. CONCLUSIONS: Our early and midterm outcomes suggest that scalloped and fenestrated TEVAR may provide an acceptable alternative treatment option for aortic arch pathologies. Large-scale studies are needed to assess the long-term durability of this technique.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Sica S, Pratesi G, Rossi G, et al. Proximal sealing in the aortic arch for inner curve disease using the custom Relay scalloped and fenestrated stent graft. J Vasc Surg. 2024. PMID: 39069017. doi:10.1016/j.jvs.2024.07.086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。